Chemed Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.0% | +2.2% | +5.7% | +7.0% | +8.7% | +7.3% | +2.9% | -0.2% | +6.1% | +7.4% | +4.1% | |
| – | +5.1% | +2.6% | +3.1% | +6.7% | +7.6% | +4.3% | -0.6% | +0.0% | +7.0% | +7.6% | +12.3% | |
| – | +8.1% | +1.2% | +11.9% | +7.5% | +11.2% | +13.6% | +9.8% | -0.6% | +4.4% | +7.0% | -11.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.8% | +4.3% | +11.5% | -2.0% | +12.7% | +8.0% | +11.1% | -2.2% | +10.1% | +7.4% | -1.7% | |
| – | +7.2% | +4.2% | +42.6% | -22.8% | +15.6% | -13.4% | +36.9% | -1.2% | +8.7% | +6.5% | -14.5% | |
| – | +9.5% | -3.1% | -36.8% | +115.5% | +5.6% | +51.4% | -12.0% | +0.1% | -0.9% | +7.6% | -7.7% | |
| – | -55.6% | +1.9% | +15.0% | +16.8% | -9.1% | -48.1% | -20.7% | +145.4% | -32.2% | -42.7% | -1.7% | |
| – | +10.7% | -1.7% | -34.0% | +104.9% | +9.2% | +51.4% | -11.5% | -5.9% | +6.3% | +14.0% | -10.9% | |
| – | +10.1% | -2.2% | -72.6% | +81.7% | +22.4% | +83.6% | +6.8% | -2.1% | -2.7% | +25.2% | -7.1% | |
| – | +11.0% | -1.4% | -9.7% | +109.4% | +7.0% | +45.3% | -15.9% | -7.0% | +9.2% | +10.8% | -12.2% | |
| – | +7.8% | -0.9% | -27.2% | +80.8% | +9.8% | +46.1% | -9.6% | -4.3% | +5.3% | +12.1% | -9.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.